Evidence mapPaperPMID 41700181Full record

ReviewWorld journal of clinical cases2026

Atherogenic index of plasma in stroke: A comprehensive review of its diagnostic, prognostic, and pathophysiological significance.

Hemanth Dhananjaya, Himanshu S Jog, Shashank Gupta, Arankesh Mahadevan, Shaylika Chauhan, Rupak Desai

Abstract readReview
In one paragraph

Review in World journal of clinical cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hemanth DhananjayaDepartment of Medicine, MS Ramaiah Medical College, Bengaluru 560054, Karnataka, India.
Himanshu S JogDepartment of Medicine, MS Ramaiah Medical College, Bengaluru 560054, Karnataka, India.
Shashank GuptaDepartment of Medicine, Mayo Clinic, Rochester, MN 55905, United States.
Arankesh MahadevanDepartment of Neurology, University of Utah Health, Salt Lake City, UT 84132, United States.
Shaylika ChauhanDepartment of Internal Medicine, Geisinger Health System, Wilkes-Barre, PA 18711, United States. drshaylikachauhan@gmail.com.
Rupak DesaiIndependent Researcher, Outcomes Research, Atlanta, GA 30033, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The atherogenic index of plasma (AIP), defined as log [triglycerides (TG)/high-density lipoprotein cholesterol], an emerging lipid-based biomarker reflecting circulating TG and high-density lipoprotein cholesterol levels, has been associated with metabolic syndrome, coronary heart disease, and atherosclerosis. Its role in cardiovascular disease has been well established, yet there is growing interest in its application in cerebrovascular conditions, particularly stroke. Stroke is one of the leading causes of death and disability worldwide; hence, there is a need for integrative biomarkers to help improve risk prediction and accuracy of prognostication. Recent studies suggest that elevated AIP is independently associated with stroke incidence, especially among individuals with diabetes, prediabetes, and metabolic syndrome. Higher AIP levels have been associated with worse stroke severity at presentation, a higher risk of early neurological deterioration, and worse short-term outcomes. This is likely a consequence of AIP indicating vascular inflammation, endothelial dysfunction, and intracranial atherosclerosis. In observational studies, AIP has demonstrated comparable or stronger associations than other markers of insulin resistance, such as the TG-glucose index and the Chinese Visceral Adiposity Index, in specific metabolic populations. It is a low-cost and easily available biomarker, making it useful in primary prevention clinics, stroke units, and for managing metabolic syndrome. Given the increasing number of observational studies and population-based data, a comprehensive synthesis is needed to evaluate AIP's diagnostic, prognostic, and pathophysiological significance in stroke. This narrative review consolidates current findings on AIP's relevance in ischemic stroke and explores its potential integration into stroke risk stratification. Existing evidence is largely observational in nature, limiting causal interpretation.

Indexed as

Atherogenic index of plasmaBiomarkerEarly neurological deteriorationInsulin resistanceIntracranial atherosclerosisIschemic stroke

Identifiers

PMID41700181
PMCPMC12897488

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.